Literature DB >> 15889128

Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.

J C Burns1, C Shimizu, H Shike, J W Newburger, R P Sundel, A L Baker, T Matsubara, Y Ishikawa, V A Brophy, S Cheng, M A Grow, L L Steiner, N Kono, R M Cantor.   

Abstract

Several compelling lines of evidence suggest an important influence of genetic variation in susceptibility to Kawasaki disease (KD), an acute vasculitis that causes coronary artery aneurysms in children. We performed a family-based genotyping study to test for association between KD and 58 genes involved in cardiovascular disease and inflammation. By analysis of a cohort of 209 KD trios using the transmission disequilibrium test, we documented the asymmetric transmission of five alleles including the interleukin-4 (IL-4) C(-589)T allele (P=0.03). Asymmetric transmission of the IL-4 C(-589)T was replicated in a second, independent cohort of 60 trios (P=0.05, combined P=0.002). Haplotypes of alleles in IL-4, colony-stimulating factor 2 (CSF2), IL-13, and transcription factor 7 (TCF7), all located in the interleukin gene cluster on 5q31, were also asymmetrically transmitted. The reported associations of KD with atopic dermatitis and allergy, elevated serum IgE levels, eosinophilia, and increased circulating numbers of monocyte/macrophages expressing the low-affinity IgE receptor (FCepsilonR2) may be related to effects of IL-4. Thus, the largest family-based genotyping study of KD patients to date suggests that genetic variation in the IL-4 gene, or regions linked to IL-4, plays an important role in KD pathogenesis and disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889128      PMCID: PMC2911125          DOI: 10.1038/sj.gene.6364225

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  55 in total

1.  High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease.

Authors:  J Hirao; S Hibi; T Andoh; T Ichimura
Journal:  Int Arch Allergy Immunol       Date:  1997-02       Impact factor: 2.749

2.  Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy.

Authors:  L J Rosenwasser; D J Klemm; J K Dresback; H Inamura; J J Mascali; M Klinnert; L Borish
Journal:  Clin Exp Allergy       Date:  1995-11       Impact factor: 5.018

3.  Tendency toward atopy in Kawasaki disease.

Authors:  S Matsuoka; K Tatara; R Nakagawa; K Mori; Y Kuroda
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

4.  High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm.

Authors:  K Takeuchi; K Yamamoto; S Kataoka; T Kakihara; A Tanaka; S Sato; M Uchiyama
Journal:  Eur J Pediatr       Date:  1997-04       Impact factor: 3.183

5.  Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.

Authors:  M C Nash; V Shah; M J Dillon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

7.  Seven-year national survey of Kawasaki disease and acute rheumatic fever.

Authors:  K A Taubert; A H Rowley; S T Shulman
Journal:  Pediatr Infect Dis J       Date:  1994-08       Impact factor: 2.129

8.  Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.

Authors:  T Matsubara; S Furukawa; T Motohashi; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

9.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

10.  Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease.

Authors:  R Y L Zee; J Hoh; S Cheng; R Reynolds; M A Grow; A Silbergleit; K Walker; L Steiner; G Zangenberg; A Fernandez-Ortiz; C Macaya; E Pintor; A Fernandez-Cruz; J Ott; K Lindpainter
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

View more
  29 in total

1.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Authors:  W B Breunis; M H Biezeveld; J Geissler; I M Kuipers; J Lam; J Ottenkamp; A Hutchinson; R Welch; S J Chanock; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

Review 2.  Kawasaki Disease update.

Authors:  Jane C Burns
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

Review 3.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

4.  Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study.

Authors:  H-C Kuo; W-C Chang; L-J Wang; S-C Li; W-P Chang
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-22       Impact factor: 6.892

5.  Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

Authors:  Chisato Shimizu; Sonia Jain; Sonia Davila; Martin L Hibberd; Kevin O Lin; Delaram Molkara; Jeffrey R Frazer; Shelly Sun; Annette L Baker; Jane W Newburger; Anne H Rowley; Stanford T Shulman; Sonia Davila; David Burgner; Willemijn B Breunis; Taco W Kuijpers; Victoria J Wright; Michael Levin; Hariklia Eleftherohorinou; Lachlan Coin; Stephen J Popper; David A Relman; Wen Fury; Calvin Lin; Scott Mellis; Adriana H Tremoulet; Jane C Burns
Journal:  Circ Cardiovasc Genet       Date:  2010-12-02

Review 6.  Kawasaki disease: novel insights into etiology and genetic susceptibility.

Authors:  Anne H Rowley
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

7.  Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.

Authors:  Manju Mamtani; Tomoyo Matsubara; Chisato Shimizu; Susumu Furukawa; Teiji Akagi; Yoshihiro Onouchi; Akira Hata; Akihiro Fujino; Weijing He; Sunil K Ahuja; Jane C Burns
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

8.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.

Authors:  Yoshihiro Onouchi; Tomohiko Gunji; Jane C Burns; Chisato Shimizu; Jane W Newburger; Mayumi Yashiro; Yoshikazu Nakamura; Hiroshi Yanagawa; Keiko Wakui; Yoshimitsu Fukushima; Fumio Kishi; Kunihiro Hamamoto; Masaru Terai; Yoshitake Sato; Kazunobu Ouchi; Tsutomu Saji; Akiyoshi Nariai; Yoichi Kaburagi; Tetsushi Yoshikawa; Kyoko Suzuki; Takeo Tanaka; Toshiro Nagai; Hideo Cho; Akihiro Fujino; Akihiro Sekine; Reiichiro Nakamichi; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Yusuke Nakamura; Akira Hata
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

9.  Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease.

Authors:  Alessandra Franco; Chisato Shimizu; Adriana H Tremoulet; Jane C Burns
Journal:  Autoimmunity       Date:  2010-06       Impact factor: 2.815

10.  A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.

Authors:  David Burgner; Sonia Davila; Willemijn B Breunis; Sarah B Ng; Yi Li; Carine Bonnard; Ling Ling; Victoria J Wright; Anbupalam Thalamuthu; Miranda Odam; Chisato Shimizu; Jane C Burns; Michael Levin; Taco W Kuijpers; Martin L Hibberd
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.